Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1

PHASE3RecruitingINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Locally Advanced Gastric Carcinoma
Interventions
DRUG

Oxaliplatin by arterial infusion plus S-1

3 cycles oxaliplatin by arterial infusion plus S-1 every 21 days as neoadjuvant chemotherapy.

DRUG

SOX neoadjuvant

3 cycles of SOX neoadjuvant chemotherapy every 21 days.

DRUG

Sintilimab neoadjuvant

3 cycles of neoadjuvant immunotherapy every 21 days.

PROCEDURE

gastrectomy plus D2 lymph node dissection

All patients, whose lesions are resectable and medically operable after 3 cycles neoadjuvant chemotherapy, will receive gastrectomy plus D2 lymph node dissection.

DRUG

SOX adjuvant, Sequential S-1

"3 cycles of SOX adjuvant chemotherapy every 21 days after surgery in both groups.~Sequential S-1 chemotherapy every 21 days till 1 year postoperation."

DRUG

Sintilimab adjuvant

3 cycles of adjuvant immunotherapy every 21 days.

Trial Locations (1)

310000

RECRUITING

Gastrointestinal Department of Second Affiliated Hospital of Zhejiang University, Hangzhou

All Listed Sponsors
lead

Zhejiang University

OTHER